@article{3093492, title = "Mechanisms of ketamine action on lipid metabolism in rats", author = "Saranteas, T and Zotos, N and Lolis, E and Stranomiti, J and Mourouzis, and C and Chantzi, C and Tesseromatis, C", journal = "European Journal of Anaesthesiology", year = "2005", volume = "22", number = "3", pages = "222-226", publisher = "Lippincott, Williams & Wilkins", issn = "0265-0215, 1365-2346", doi = "10.1017/S0265021505000384", keywords = "anaesthetic agents; ketamine; lipids; lipoprotein lipase", abstract = "Background and objective: This study was conducted to determine the effect of ketamine on metabolic homoeostasis and particularly in lipoprotein lipase (LPL) activity in adipose tissue. Methods: Sixty male Wistar rats were divided into six groups of 10 each. Group A served as controls, while Groups B-F received, respectively, ketamine 60, 80, 100, 120 and 140 mg kg(-1) intraperitoneally. The animals were sacrificed 20 min after the administration of ketamine. Insulin concentrations in plasma and total cholesterol, triglyceride, high-density lipoprotein (HDL) and free fatty acid (FFA) concentrations in serum were measured. LPL activity in adipose tissue and medium-chain acyl-CoA dehydrogenase (MCAD) content in muscle were determined. Results: FFA concentrations in serum significantly increased from the second lowest dose of ketamine. Insulin concentrations in plasma did not exhibit any significant difference between groups. MCAD levels were 0.5-fold more in Group F than in Group A, while there were no significant differences between control group and Groups B-E. Furthermore, high concentrations (120 and 140 mg kg(-1)) of ketamine interfered with in metabolic homoeostasis by significantly reducing LPL activity, thus elevating triglyceride concentrations in serum without affecting cholesterol and HDL metabolism. Conclusions: Ketamine induces various metabolic effects due to changes in adipose LPL activity and MCAD levels in muscles. These findings seem to be significant only at high doses." }